Light-sensitive patients including such as xeroderma pigmentosum, chronic actinic dermatitis, photosensitivity dermatitis, drug-induced photosensitivity
Conditions
Sponsors
Kobe University Graduate School of Medicine(Kobe University Hospital)
Kobe University Graduate School of Medicine(Kobe University Hospital) Department of Dermatology, Hokkaido University Graduate School of Medicine(Hokkaido University Hospital) Graduate School of Medicine, Kyoto University(Kyoto University Hospital) Kyushu University, Graduate School of Medical Sciences(Kyushu University Hospital) Faculty of life science, Kumamoto University(Kumamoto University Hospital) Kanagawa Chirdren'
s Medicalcenter Rikako'
s Clinic of Dermatology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with photosensitivity, who is determined that the use of this reserch article is useful therapeutically 2.Regardless of age or sex 3.Patients (whose legal representative in the case of minors) are in agreement In addition, we define photosensitivity as follows in this study. 1.photosensitivity disease including such as xeroderma pigmentosum, chronic actinic dermatitis, photosensitivity dermatitis,drug-induced photosensitivity 2.the diseases exacerbated by sun exposure including such as systemic lupus erythematosus, discoid lupus erythematosus, subacute cutaneous lupus erythematosus, dermatomyositis, rosacea-like dermatitis, Sjogren's syndrome 3.the diseases which is desirable to avoid sun exposure therapeutically for in improving disease, including atopic dermatitis, pigment spots (such as after laser treatment).
Exclusion criteria
Exclusion criteria: 1.Those who have experience with the use of sunscreen agents, resulted in a skin severe symptoms in the past. 2.Those who have skin eruption on the application area of this research article. 3.The case that the interference of this reserch article and other topical product is expected. 4.Pregnant or nursing women 5.Those who can not (in principle) be examined after 4 weeks 6.Those who are deemed inappropriate to participate in this study by doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the safety(10% or less rate of adverse effect | — |
Secondary
| Measure | Time frame |
|---|---|
| the usability(the changes of skin findings and cytokines in the stratum corneum) | — |
Countries
Japan
Contacts
Public ContactFukunaga Atsushi
Kobe University Graduate School of Medicine(Kobe University Hospital) Department of Dermatology
Outcome results
None listed